Jaykumar Thumar
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 9
- Pancreatic and Hepatic Oncology Research 5
- Cancer Treatment and Pharmacology 3
- Cancer-related Molecular Pathways 1
-
- Renal cell carcinoma treatment 2
- Co-authors
- Howard S. Höchster (7 shared papers)Jill Lacy (7 shared papers)Harriet M. Kluger (2 shared papers)Katherine A. Guthrie (3 shared papers)E. Gabriela Chiorean (3 shared papers)Shannon McDonough (2 shared papers)Ramesh K. Ramanathan (2 shared papers)David K. Han (2 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Molecular & Cellular Proteomics (2 papers)Molecular Cancer (1 paper)Urology (1 paper)Medical Oncology (1 paper)
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Jaykumar Thumar
16 papers receiving 775 citations
Jaykumar Thumar's Hit Papers
Peers
Comparison fields: 5 of 62
- Oncology 445
- Cancer Research 155
- Immunology 141
- Spectroscopy 68
- Pulmonary and Respiratory Medicine 104
Countries citing papers authored by Jaykumar Thumar
This map shows the geographic impact of Jaykumar Thumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaykumar Thumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaykumar Thumar more than expected).
Fields of papers citing papers by Jaykumar Thumar
This network shows the impact of papers produced by Jaykumar Thumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaykumar Thumar. The network helps show where Jaykumar Thumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaykumar Thumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313 Hit paper breakdown → | 2019 | 256 |
| 2 | 2007 | 135 | |
| 3 | 2012 | 118 | |
| 4 | 2023 | 61 | |
| 5 | 2014 | 58 | |
| 6 | 2006 | 50 | |
| 7 | 2011 | 30 | |
| 8 | Ipilimumab: a promising immunotherapy for melanoma. | 2010 | 27 |
| 9 | 2018 | 24 | |
| 10 | 2012 | 9 | |
| 11 | 2012 | 7 | |
| 12 | 2019 | 5 | |
| 13 | 2019 | 2 | |
| 14 | 2020 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2022 | 1 |
About Jaykumar Thumar
Jaykumar Thumar is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 16 papers that have together received 786 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (5 papers), Cancer Treatment and Pharmacology (3 papers), Renal cell carcinoma treatment (2 papers), Cancer Genomics and Diagnostics (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Advanced Proteomics Techniques and Applications (1 paper), Hormonal and reproductive studies (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Oncology (445 citations), Cancer Research (155 citations), Immunology (141 citations), Spectroscopy (68 citations) and Pulmonary and Respiratory Medicine (104 citations). Jaykumar Thumar has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Howard S. Höchster, Jill Lacy, Harriet M. Kluger, Katherine A. Guthrie, E. Gabriela Chiorean, Shannon McDonough, Ramesh K. Ramanathan, David K. Han, Rakesh Gaur and Xiangyu Cong. Their work appears in journals such as Journal of Clinical Oncology, Molecular & Cellular Proteomics, Molecular Cancer, Urology and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.